APLS vs GILD: Which Stock is Better?
Side-by-side comparison of Apellis Pharmaceuticals Inc and Gilead Sciences Inc in 2026
APLS
Apellis Pharmaceuticals Inc
$40.88
GILD
Gilead Sciences Inc
$138.67
Key Metrics Comparison
| Metric | APLS | GILD | Winner |
|---|---|---|---|
| Market Cap | $5.22B | $174.33B | GILD |
| P/E Ratio | 226.94 | 20.72 | GILD |
| EPS (TTM) | $0.18 | $6.78 | GILD |
| Revenue Growth | -0.1% | 0.0% | GILD |
| Gross Margin | 60.3% | 78.8% | GILD |
Analyze APLS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APLS or GILD a better investment?
Comparing APLS and GILD: Apellis Pharmaceuticals Inc has a market cap of $5.22B while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APLS and GILD?
APLS (Apellis Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APLS or GILD?
Based on P/E ratios, GILD trades at a lower multiple (20.7x vs 226.9x).
Which is growing faster: APLS or GILD?
GILD has higher revenue growth at 0.0% vs -0.1% for APLS.
Which company is more profitable: APLS or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 60.3% for APLS.
Which is the larger company: APLS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $5.22B for APLS.
Should I buy APLS or GILD in 2026?
Both APLS and GILD have investment merit. APLS trades at $40.88 while GILD trades at $138.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APLS and GILD stock?
Key differences: Market Cap ($5.22B vs $174.33B), P/E Ratio (226.9x vs 20.7x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (60.3% vs 78.8%).